BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32887585)

  • 1. Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank.
    Huang CY; Li LH; Hsu WT; Cheng YC; Nicholson MW; Liu CL; Ting CY; Ko HW; Syu SH; Wen CH; Yan Z; Huang HP; Su HL; Chiang PM; Shen CN; Chen HF; Yen BLJ; Lu HE; Hwang SM; Chiou SH; Ho HN; Wu JY; Kamp TJ; Wu JC; Hsieh PCH
    J Biomed Sci; 2020 Sep; 27(1):92. PubMed ID: 32887585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
    Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
    PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide CNV analysis in mouse induced pluripotent stem cells reveals dosage effect of pluripotent factors on genome integrity.
    Chen Y; Guo L; Chen J; Zhao X; Zhou W; Zhang C; Wang J; Jin L; Pei D; Zhang F
    BMC Genomics; 2014 Jan; 15():79. PubMed ID: 24472662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity.
    Steichen C; Luce E; Maluenda J; Tosca L; Moreno-Gimeno I; Desterke C; Dianat N; Goulinet-Mainot S; Awan-Toor S; Burks D; Marie J; Weber A; Tachdjian G; Melki J; Dubart-Kupperschmitt A
    Stem Cells Transl Med; 2014 Jun; 3(6):686-91. PubMed ID: 24736403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of somatic cell sources in the maturation degree of human induced pluripotent stem cell-derived cardiomyocytes.
    Pianezzi E; Altomare C; Bolis S; Balbi C; Torre T; Rinaldi A; Camici GG; Barile L; Vassalli G
    Biochim Biophys Acta Mol Cell Res; 2020 Mar; 1867(3):118538. PubMed ID: 31472168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells.
    Abyzov A; Mariani J; Palejev D; Zhang Y; Haney MS; Tomasini L; Ferrandino AF; Rosenberg Belmaker LA; Szekely A; Wilson M; Kocabas A; Calixto NE; Grigorenko EL; Huttner A; Chawarska K; Weissman S; Urban AE; Gerstein M; Vaccarino FM
    Nature; 2012 Dec; 492(7429):438-42. PubMed ID: 23160490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Specific and Genome-Edited Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Brugada Syndrome.
    Liang P; Sallam K; Wu H; Li Y; Itzhaki I; Garg P; Zhang Y; Vermglinchan V; Lan F; Gu M; Gong T; Zhuge Y; He C; Ebert AD; Sanchez-Freire V; Churko J; Hu S; Sharma A; Lam CK; Scheinman MM; Bers DM; Wu JC
    J Am Coll Cardiol; 2016 Nov; 68(19):2086-2096. PubMed ID: 27810048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor-induced Reprogramming and Zinc Finger Nuclease-aided Gene Targeting Cause Different Genome Instability in β-Thalassemia Induced Pluripotent Stem Cells (iPSCs).
    Ma N; Shan Y; Liao B; Kong G; Wang C; Huang K; Zhang H; Cai X; Chen S; Pei D; Chen N; Pan G
    J Biol Chem; 2015 May; 290(19):12079-89. PubMed ID: 25795783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Stability and Differentiation Potential of Cryopreserved cGMP-Compliant Human Induced Pluripotent Stem Cells.
    Shafa M; Walsh T; Panchalingam KM; Richardson T; Menendez L; Tian X; Suresh Babu S; Dadgar S; Beller J; Yang F; Baghbaderani BA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iPSCORE: A Resource of 222 iPSC Lines Enabling Functional Characterization of Genetic Variation across a Variety of Cell Types.
    Panopoulos AD; D'Antonio M; Benaglio P; Williams R; Hashem SI; Schuldt BM; DeBoever C; Arias AD; Garcia M; Nelson BC; Harismendy O; Jakubosky DA; Donovan MKR; Greenwald WW; Farnam K; Cook M; Borja V; Miller CA; Grinstein JD; Drees F; Okubo J; Diffenderfer KE; Hishida Y; Modesto V; Dargitz CT; Feiring R; Zhao C; Aguirre A; McGarry TJ; Matsui H; Li H; Reyna J; Rao F; O'Connor DT; Yeo GW; Evans SM; Chi NC; Jepsen K; Nariai N; Müller FJ; Goldstein LSB; Izpisua Belmonte JC; Adler E; Loring JF; Berggren WT; D'Antonio-Chronowska A; Smith EN; Frazer KA
    Stem Cell Reports; 2017 Apr; 8(4):1086-1100. PubMed ID: 28410642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
    Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced pluripotent stem cell derived cardiac models: effects of Thymosin β4.
    Ziegler T; Hinkel R; Kupatt C
    Expert Opin Biol Ther; 2018 Jul; 18(sup1):111-120. PubMed ID: 30063852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.
    Yoshida Y; Yamanaka S
    Circ Res; 2017 Jun; 120(12):1958-1968. PubMed ID: 28596174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.
    Kolanowski TJ; Busek M; Schubert M; Dmitrieva A; Binnewerg B; Pöche J; Fisher K; Schmieder F; Grünzner S; Hansen S; Richter A; El-Armouche A; Sonntag F; Guan K
    Acta Biomater; 2020 Jan; 102():273-286. PubMed ID: 31778832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
    Liu Y; Deng W
    Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do Induced Pluripotent Stem Cell Characteristics Correlate with Efficient In Vitro Smooth Muscle Cell Differentiation? A Comparison of Three Patient-Derived Induced Pluripotent Stem Cell Lines.
    Zhou Y; Kang G; Wen Y; Briggs M; Sebastiano V; Pederson R; Chen B
    Stem Cells Dev; 2018 Oct; 27(20):1438-1448. PubMed ID: 30153084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.
    Chuang CY; Huang MC; Chen HF; Tseng LH; Yu CY; Stone L; Huang HP; Ho HN; Kuo HC
    Stem Cell Res Ther; 2015 Feb; 6(1):14. PubMed ID: 25889179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
    Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and characterization of human induced pluripotent stem cells (iPSCs) from hand osteoarthritis patient-derived fibroblasts.
    Castro-Viñuelas R; Sanjurjo-Rodríguez C; Piñeiro-Ramil M; Hermida-Gómez T; Rodríguez-Fernández S; Oreiro N; de Toro J; Fuentes I; Blanco FJ; Díaz-Prado S
    Sci Rep; 2020 Mar; 10(1):4272. PubMed ID: 32144293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.